Direkt zum Inhalt
Merck

Bioequivalence Study of Atorvastatin Tablets in Healthy Pakistani Volunteers.

Therapie (2015-02-14)
Sohail Mohammad, Usman Arshad, Nasir Abbass, Irfan Parvez, Ghulam Abbas, Wajahat Mahmood
ZUSAMMENFASSUNG

A two way, randomized cross-over bioequivalence study was conducted to analyse the rate and extent of absorption of atorvastatin after a single dose of 80 mg atorvastatin as atorvastatin calcium tablets. The study was carried out using healthy male volunteers (N = 24). A high performance liquid chromatography method was employed to determine the level of drug in human plasma. It was concluded that the test and the reference drug exhibited comparable values of pharmacokinetic parameters. It was also concluded that since there was no significant difference between the rate and extent of absorption of the drug from the test and the reference formulations: these two formulations could thus be declared bioequivalent.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumphosphat, 96%
Sigma-Aldrich
Progesteron, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Progesteron, ≥99%
Sigma-Aldrich
Acetonitril, anhydrous, 99.8%
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
Progesteron, meets USP testing specifications
Sigma-Aldrich
Acetonitril, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Progesteron, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
Methanol, NMR reference standard
Sigma-Aldrich
Methanol -Lösung, NMR reference standard, 4% in methanol-d4 (99.8 atom % D), NMR tube size 3 mm × 8 in.
Sigma-Aldrich
Methanol-12C, 99.95 atom % 12C
Sigma-Aldrich
Acetonitril